Shandong Weigao establishes Indonesia JV, repurchases shares

Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) announced the formation of Oneject Wego Medical, a joint venture in Indonesia, on November 6, 2025. Weigao International Holding, a wholly-owned subsidiary, will hold 45% of the joint venture, with PT Oneject Indonesia (the "JV Partner") holding 55%.

The joint venture will focus on manufacturing and selling intravenous catheters, infusion sets, and other medical consumables, targeting localized production in Indonesia. The company expects this venture to expand its global market reach and enhance synergy with its existing business.

In a related financial disclosure, Shandong Weigao reported the repurchase of 682,000 H shares on November 10, 2025, at an aggregate price of HK$3,651,140. The repurchase prices ranged from HK$5.3 to HK$5.42 per share. This transaction resulted in a 0.0152% change in issued shares (excluding treasury shares) from the opening balance of 4,499,213,524 shares on November 7, 2025.

The company now holds 23,800,800 treasury shares, an increase from 23,118,800. The total number of shares authorized for repurchase under the mandate granted on May 27, 2025, is 451,560,392, with 17,152,400 shares repurchased to date on the Exchange.